A gene expression profile for endochondral bone formation: Oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps

Bone

Volumn 33, Issue 1, 2003, Pages 46-63

  Clancy, Brian M ^a   Johnson, Joyce D ^a   Lambert, Andre Jean ^a   Rezvankhah, Saeid ^a   Wong, Anthony ^a   Resmini, Christine ^a   Feldman, Jeffrey L ^a   Leppanen, Scott ^a   Pittman, Debra D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; BUFFER; COLLAGEN TYPE 10; COLLAGEN TYPE 2; EOSIN; GENE PRODUCT; HEMATOXYLIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 23; MESSENGER RNA; OLIGONUCLEOTIDE; OSTEOCALCIN; PROCOLLAGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; CARTILAGE; CARTILAGE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA MICROARRAY; ENCHONDRAL OSSIFICATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HYBRIDIZATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PROTEIN FUNCTION; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; RADIOGRAPHY; SCID MOUSE; STAINING; TISSUE SECTION; UNINDEXED SEQUENCE;

EID: 0041706100     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00116-9     Document Type: Article

References (62)

1. Cohen M.M. Merging the old skeletal biology with the new. I. Intramembranous ossification, endochondral ossification, ectopic bone, secondary cartilage, and pathologic considerations. J Craniofac Genet Dev Biol. 20:2000;84-93.
2. McCarthy T.L., Ji C., Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med. 11:2000;409-422.
3. Ji X., Chen D., Xu C., Harris S.E., Mundy G.R., Yoneda T. Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab. 18:2000;132-139.
4. Seth A., Lee B.K., Qi S., Vary C.P. Coordinate expression of novel genes during osteoblast differentiation. J Bone Miner Res. 15:2000;1683-1696.
5. Hadjiargyrou M., Rightmire E.P., Ando T., Lombardo F.T. The E11 osteoblastic lineage marker is differentially expressed during fracture healing. Bone. 29:2001;149-154.
6. Kearns A.E., Donohue M.M., Sanyal B., Demay M.B. Cloning and characterization of a novel protein kinase that impairs osteoblast differentiation in vitro. J Biol Chem. 276:2001;42213-42218.
7. Safadi F.F., Xu J., Smock S.L., Rico M.C., Owen T.A., Popoff S.N. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem. 84:2001;12-26.
8. Sommerfeldt D.W., Zhi J., Rubin C.T., Hadjiargyrou M. Proline-rich transcript of the brain (prtb) is a serum-responsive gene in osteoblasts and upregulated during adhesion. J Cell Biochem. 84:2002;301-308.
9. Zhi J., Sommerfeldt D.W., Rubin C.T., Hadjiargyrou M. Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentialtion. J Bone Miner Res. 16:2001;1994-2004.
10. Beck G.R., Zerler B., Moran E. Gene array analysis of osteoblast differentiation. Cell Growth Differ. 12:2001;61-83.
11. Doi M., Nagano A., Nakamura Y. Geneome-wide screening by cDNA microarrays of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem Biophys Res Commun. 290:2002;381-390.
12. Huang W., Carlsen B., Rudkin G.H., Shah N., Chung C., Ishida K., Yamaguchi D.T., Miller T.A. Effect of serial passage on gene expression in MC3T3-E1 preosteoblastic cells a microarray study . Biochem Biophys Res Commun. 281:2001;1120-1126.
13. Lomri A., Lemonnier J., Delannoy P., Marie P.J. Increased expression of protein kinase Calpha, interleukin 1alpha, and RhoA guanosine 5′-triphosphatase in osteoblasts expressing the ser252trp fibroblast growth factor 2 receptor apert mutation identification by analysis of complementary DNA microarray . J Bone Miner Res. 16:2001;705-712.
14. Raouf A., Seth A. Discovery of osteoblast-associated genes using cDNA microarrays. Bone. 30:2002;463-471.
15. Vaes B.L.T., Dechering K.J., Feijen A., Hendriks J.M.A., Lefevre C., Mummery C.L., Olijve W., Van Zoelen E.J.J., Steegenga W.T. Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res. 17:2002;2106-2118.
16. Vincenti M.P., Brinckerhoff C.E. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res. 3:2001;381-388.
17. Locklin R.M., Riggs B.L., Hicok K.C., Horton H.F., Byrne M.C., Khosla S. Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J Bone Miner Res. 16:2001;2192-2204.
18. Theilhaber J., Connolly T., Roman-Roman S., Bushnell S., Jackson A., Call K., Garcia T., Baron R. Finding genes in the C2C12 osteogenic pathway by K-nearest-neighbor classification of expression data. Genome Res. 12:2002;165-176.
19. Byrne M.C., Whitley M.Z. Use of oligonucleotide arrays for gene expression monitoring. Kessler C. Nonradioactive labeling and detection of biomolecules. second ed. 2000;738-743 Heidelberg, Germany: Springer-Verlag.
20. Lockhart D.J., Dong H., Byrne M.C., Follettie M.V., Gallo M.V., Chee M.S., Mittmann M., Wang C., Kobayashi M., Horton H., Brown E.L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 14:1996;1675-1680.
21. 3, independent of its carboxyl-terminal domain. J Biol Chem. 726:2001;21943-21950.
22. Kireeva M.L., Mo F., Yang G.P., Lau L.F. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol. 16:1996;1326-1334.
23. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., Coller H., Loh M.L., Downing J.R., Caligiuri M.A., Bloomfield C.D., Lander E.S. Molecular classification of cancer class discovery and class prediction by gene expression monitoring . Science. 286:1999;531-537.
24. Hanna E., Schrieve D.C., Ratanatharathorn V., Xia X., Breau R., Suen J., Li S. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 61:2001;2376-2380.
25. Lin Y., Furukawa Y., Tsunoda T., Yue C., Yang K., Nakamura Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene. 21:2002;4120-4128.
26. Posner L.J., Miligkos T., Gilles J.A., Carnes D.L., Taddeo D.R., Graves D.T. Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone. 21:1997;321-327.
27. Lescher B., Haenig B., Kispert A. sFRP-2 is a target of the wnt-4 signaling pathway in the developing metanephric kidney. Dev Dyn. 213:1998;440-451.
28. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327:1993;125-130.
29. Fan W.H., Pech M., Karnovsky M.J. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vivo. Eur J Cell Biol. 79:2000;915-923.
30. Hadjiargyrou M., Ahrens W., Rubin C.T. Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. J Bone Miner Res. 15:2000;1014-1023.
31. Nakanishi T., Kimura Y., Tamura T., Ichikawa H., Yamaai Y., Sugimoto T., Takigawa M. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun. 234:1997;206-210.
32. Xu J., Smock S.L., Safadi F.F., Rosenzweig A.B., Odgren P.R., Marks S.C., Owen T.A., Popoff S.N. Cloning the full-length cDNA for rat connective tissue growth factor Implications for skeletal development . J Cell Biochem. 77:2000;103-115.
33. Miller E.J. Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains. Biochemistry. 10:1971;1652-1659.
34. Trelstad R.L., Kang A.H., Igarashi S., Gross J. Isolation of two distinct collagens from chick cartilage. Biochemistry. 9:1970;4993-4998.
35. Vornehm S.I., Dudhia J., Von der Mark K., Aigner T. Expression of collagen types IX and XI and other major cartilage matrix components by human chondrocytes in vivo. Matrix Biol. 15:1996;91-98.
36. Habuchi H., Conrad H.E., Glaser J.H. Coordinate regulation of collagen and alkaline phosphatase levels in chick embryo chondrocytes. J Biol Chem. 260:1985;13029-13034.
37. Leboy P.S., Vaias L., Uschmann B., Golub E., Adams S.L., Pacifici M. Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultured chick chondrocytes. J Biol Chem. 264:1989;17281-17286.
38. Gibson G. Active role of chondrocyte apoptosis in endochondral ossification. Microsc Res Tech. 43:1998;191-204.
39. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1 a transcriptional activator of osteoblast differentiation . Cell. 89:1997;747-754.
40. Thirunavukkarasu K., Halladay D.L., Miles R.R., Yang X., Galvin R.J.S., Chandrasekhar S., Martin T.J., Onyia J.E. The osteoblast-specific transcription factor cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem. 275:2000;25163-25172.
41. Lian J.B., Stein G.S., Stein J.L., Van Wijnen A.J. Osteocalcin gene promoter unlocking the secrets for regulation of osteoblast growth and differentiation . J Cell Biochem Suppl. 30-31:1998;62-72.
42. Drake F.H., Dodds R.A., James I.E., Conner J.R., DeBouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K but not B, L or S is abundantly expressed in human osteoclasts. J Biol Chem. 271:1996;12511-12516.
43. Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T. Molecular cloning of human cDNA for cathepsin K. Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun. 206:1995;89-96.
44. Reponen P., Sahlberg C., Munaut C., Thesleff I., Tryggvason K. High expression of 92-kd type IV collagenase (gelatinase b) in the osteoclast lineage during mouse development. J Cell Biol. 124:1994;1091-1102.
45. Rice D.P., Kim H.J., Thesleff I. Detection of gelatinase b expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone. 21:1997;479-486.
46. Bach I. The LIM domain regulation by association . Mech Dev. 91:2000;5-17.
47. Heximer S.P., Watson N., Linder M.E., Blumer K.J., Helper J.R. RGS2/GOS8 is a selective inhibitor of Gqa function. Proc Natl Acad Sci USA. 94:1997;14389-14393.
48. Miles R.R., Sluka J.P., Santerre R.F., Hale L.V., Bloem L., Boguslawski G., Thirunavukkarasu K., Hock J.M., Onyia J.E. Dynamic regulation of RGS2 in bone potential new insights into parathyroid hormone signaling mechanisms . Endocrinology. 141:2000;28-36.
49. McGeehan G.M., Becherer J.D., Bast R.C., Boyer C.M., Champion B., Connolly K.M., Conway J.G., Furdon P., Karp S., Kidao S., McElroy A.B., Nichols J., Pryzwansky K.M., Schoenen F., Sekut L., Truesdale A., Verghese M., Warner J., Ways J.P. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
50. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K., Kronheim S.R., Petersen M., Gerhart M., Kozlosky C.J., March C.J., Black R.A. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:1994;218-220.
51. Couet J., Sar S., Jolivet A., Hai M., Milgrom E., Misrahi M. Shedding of human thyrotropin receptor ectodomain. J Biol Chem. 271:1996;4545-4552.
52. Werb Z. ECM and cell surface proteolysis Regulating cellular ecology . Cell. 91:1997;439-442.
53. Velasco G., Pendas A.M., Fueyo A., Knauper V., Murphy G., Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 274:1999;4570-4576.
54. Pei D. CA-MMP a matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch . FEBS Lett. 457:1999;262-270.
55. Pei D., Kang T., Qi H. Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem. 275:2000;33988-33997.
56. Ohnishi J., Ohnishi E., Jin M., Hirano W., Nakane D., Matsui H., Kimura A., Sawa H., Nakayama K., Shibuya H., Nagashima K., Takahashi T. Cloning and characterization of a rat ortholog of MMP-23 (matrix metalloproteinase-23), a unique type of membrane-anchored matrix metalloproteinase and conditioned switching of its expression during the ovarian follicular development. Mol Endocrinol. 15:2001;747-764.
57. Elson G.C., Graber P., Losberger C., Herren S., Gretener D., Menoud L.N., Wells T.N., Kosco-Vilbois M.H., Gauchat J.F. Cytokine-like factor-1, a novel soluble protein, shares homolgy with members of the cytokine type I receptor family. J Immunol. 161:1998;1371-1379.
58. Elson G.C.A., Lelievre E., Guillet C., Chevalier S., Plun-Favreau H., Froger J., Suard I., de Coignac A.B., Delneste Y., Bonnefoy J., Gauchat J., Gascan H. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci. 3:2000;867-872.
59. Lelievre E., Plun-Favreau H., Chevalier S., Froger J., Guillet C., Elson G.C.A., Gauchat J., Gascan H. Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine. J Biol Chem. 276:2001;22476-22484.
60. Bellido T., Stahl N., Farruggella T.J., Borba V., Yancopoulos G.D., Manolagas S.C. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest. 97:1996;431-437.
61. Heymann D., Rousselle A. gp130 cytokine family and bone cells. Cytokine. 12:2000;1455-1468.
62. Alexander W.S., Rakar S., Robb L., Farley A., Willson T.A., Zhang J.G., Hartley L., Kikuchi Y., Kojima T., Nomura H., Hasegawa M., Maeda M., Fabri L., Jachno K., Nash A., Metcalf D., Nicola N.A., Hiton D.J. Suckling defect in mice lacking the soluble haemopoietin receptor NR6. Curr Biol. 9:1999;605-608.